The basics: small chains of amino acids
Peptides are short chains of amino acids — the same twenty building blocks that make up proteins, just far smaller. The line between a peptide and a protein is loosely drawn by size: chains of roughly two to fifty amino acids are usually called peptides, while longer chains are proteins. Insulin, at 51 amino acids, sits right on that border and is one of the most famous peptide medicines in history.
The exact sequence of amino acids gives each peptide a specific three-dimensional shape, and that shape is what lets it fit into a receptor like a key into a lock. This is why two peptides that differ by a single amino acid can behave very differently in the body. It's also why peptides are described in 'structure/function' terms — what their structure lets them bind to — rather than as blunt instruments.
Your body already runs on peptides
Peptides aren't exotic. Your body manufactures and uses hundreds of them as signaling molecules — chemical messages that tell cells what to do. Hormones like insulin, glucagon, oxytocin, and growth-hormone-releasing hormone are all peptides. So are many of the molecules that regulate appetite, mood, immune response, and tissue maintenance.
Because they're signals rather than bulk materials, peptides typically act at very low concentrations and are broken down quickly once their message is delivered. That short lifespan in the bloodstream is a recurring theme in how peptide medicines are designed and given.
How peptides become medicines
When a peptide is used therapeutically, the goal is usually to mimic, extend, or modulate one of these natural signals. Some medicines are exact copies of a human peptide; others are engineered analogs — the sequence is tweaked so the molecule lasts longer or binds more selectively. GLP-1 medicines like semaglutide are a well-known example of engineered peptide analogs.
At Clyne, peptide therapy is prescription-only. A licensed provider reviews your health history, medications, and goals and decides whether a peptide is appropriate for you — and which one, if any. We deliberately focus on honest, structure-and-function information instead of hype, and we don't make promises about outcomes.
The evidence varies — a lot
The single most important thing to understand about peptides is that the quality of human evidence ranges enormously from one molecule to the next. A handful — like bremelanotide (PT-141) and tesamorelin — are FDA-approved medicines with randomized controlled trials behind them. Many others have only small studies, animal data, or mechanistic reasoning, which is a much weaker foundation.
Strong evidence in a test tube or in mice does not reliably predict what happens in people. We try to be explicit about which tier each peptide falls into on its individual profile, and where the data is thin, we say so rather than papering over it.